We conclude that NAFL patients exhibited a balance between pro-inflammatory (IL-1β, IL-6, IL-12, and TNF) and regulatory (IL-10) cytokines concentrations, which were associated with the beginning of metabolic alterations in NAFLD context. The gene discussed is IL1B; the disease is non-alcoholic fatty liver.